Neoadjuvant FOLFOX Chemotherapy for Colon Cancer: Long-Term Chemotherapy-Induced Peripheral Neuropathy and Impact on Quality of Life
CompletedOBSERVATIONAL
Enrollment
54
Participants
Timeline
Start Date
March 19, 2021
Primary Completion Date
May 20, 2024
Study Completion Date
May 20, 2024
Conditions
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Trial Locations (1)
125284
P. Hertsen Moscow Oncology Research Institute, Moscow
All Listed Sponsors
collaborator
Jiaxing University
UNKNOWN
lead
P. Herzen Moscow Oncology Research Institute
OTHER_GOV
NCT06844409 - Neoadjuvant FOLFOX Chemotherapy for Colon Cancer: Long-Term Chemotherapy-Induced Peripheral Neuropathy and Impact on Quality of Life | Biotech Hunter | Biotech Hunter